Lifang Pharmaceutical subsidiary's eye drop application accepted

Lifang Pharmaceutical's subsidiary, Hefei Norite Pharmaceutical, has received a "Notice of Acceptance" from China's National Medical Products Administration for its polyvinyl alcohol eye drops. These eye drops function as a lubricant to alleviate symptoms such as dry eyes, foreign body sensation, and eye fatigue. The announcement was made by 36Kr, which also noted other unrelated financial and market news. AI

RANK_REASON The item reports on a regulatory acceptance for a specific pharmaceutical product, which falls under the 'tool' category as it's not a frontier release or significant industry event.

Read on 36氪 (36Kr) →

• 36Kr
• Hefei Norite Pharmaceutical
• Lifang Pharmaceutical
• National Medical Products Administration
• polyvinyl alcohol eye drops
• WAIC 2026

• product

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →